{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:12:29Z","timestamp":1780661549881,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-026-02121-3","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:24:42Z","timestamp":1772558682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A randomized controlled trial of drug-coated balloon versus conventional balloon angioplasty in diabetic patients with lower extremity arteriosclerosis obliterans: outcomes in ankle-brachial index and restenosis rate"],"prefix":"10.1186","volume":"18","author":[{"given":"Bolong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanchong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyong","family":"Tuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangchun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"2121_CR1","doi-asserted-by":"publisher","unstructured":"Khan AW, Jandeleit-Dahm KAM. Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches. Nat Reviews Cardiol. 2025;Advance online publication. https:\/\/doi.org\/10.1038\/s41569-024-01115-w","DOI":"10.1038\/s41569-024-01115-w"},{"issue":"5","key":"2121_CR2","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/jcm13051471","volume":"13","author":"M Piechocki","year":"2024","unstructured":"Piechocki M, Przew\u0142ocki T, Pieni\u0105\u017cek P, Trystu\u0142a M, Podolec J, Kab\u0142ak-Ziembicka AA, Non-Coronary. Peripheral arterial atherosclerotic disease (Carotid, Renal, lower Limb) in elderly patients\u2014A review: part I\u2014Epidemiology, risk Factors, and Atherosclerosis-Related diversities in elderly patients. J Clin Med. 2024;13(5):1471. https:\/\/doi.org\/10.3390\/jcm13051471.","journal-title":"J Clin Med"},{"issue":"5","key":"2121_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13098-023-01247-y","volume":"16","author":"S Yu","year":"2024","unstructured":"Yu S, Du J. Current views on Selenoprotein S in the pathophysiological processes of diabetes-induced atherosclerosis: potential therapeutics and underlying biomarkers. Diabetol Metab Syndr. 2024;16(5):5. https:\/\/doi.org\/10.1186\/s13098-023-01247-y.","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"2121_CR4","doi-asserted-by":"publisher","first-page":"e14931","DOI":"10.1111\/iwj.14931","volume":"21","author":"Y Luo","year":"2024","unstructured":"Luo Y, Liu C, Li C, Jin M, Pi L, Jin Z. The incidence of lower extremity amputation and its associated risk factors in patients with diabetic foot ulcers: A meta-analysis. Int Wound J. 2024;21(7):e14931. https:\/\/doi.org\/10.1111\/iwj.14931.","journal-title":"Int Wound J"},{"issue":"2","key":"2121_CR5","doi-asserted-by":"publisher","first-page":"102397","DOI":"10.1016\/j.dsx.2022.102397","volume":"16","author":"BT Rodrigues","year":"2022","unstructured":"Rodrigues BT, Vangaveti VN, Urkude R, Biros E, Malabu UH. Prevalence and risk factors of lower limb amputations in patients with diabetic foot ulcers: A systematic review and meta-analysis. Diabetes Metabolic Syndrome: Clin Res Reviews. 2022;16(2):102397. https:\/\/doi.org\/10.1016\/j.dsx.2022.102397.","journal-title":"Diabetes Metabolic Syndrome: Clin Res Reviews"},{"issue":"9","key":"2121_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4239\/wjd.v11.i9.391","volume":"11","author":"A Rathnayake","year":"2020","unstructured":"Rathnayake A, Saboo A, Malabu UH, Falhammar H. Lower extremity amputations and long-term outcomes in diabetic foot ulcers: A systematic review. World J Diabetes. 2020;11(9):391\u20139. https:\/\/doi.org\/10.4239\/wjd.v11.i9.391.","journal-title":"World J Diabetes"},{"issue":"12","key":"2121_CR7","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.4239\/wjd.v13.i12.1014","volume":"13","author":"L Yang","year":"2022","unstructured":"Yang L, Rong GC, Wu QN. Diabetic foot ulcer: challenges and future. World J Diabetes. 2022;13(12):1014\u201334. https:\/\/doi.org\/10.4239\/wjd.v13.i12.1014.","journal-title":"World J Diabetes"},{"issue":"2","key":"2121_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.34172\/apb.2023.025","volume":"13","author":"AA Arabzadeh","year":"2022","unstructured":"Arabzadeh AA, Faghfuri E, Razi Soofiyani S, et al. Current and novel emerging medical therapies for peripheral artery disease: A literature review. Adv Pharm Bull. 2022;13(2):259\u201368. https:\/\/doi.org\/10.34172\/apb.2023.025.","journal-title":"Adv Pharm Bull"},{"key":"2121_CR9","doi-asserted-by":"publisher","unstructured":"Wang R, Gu S, Kim YH et al. Diabetic Wound Repair: From Mechanism to Therapeutic Opportunities. MedComm (2020). 2025;6(10):e70406. https:\/\/doi.org\/10.1002\/mco2.70406","DOI":"10.1002\/mco2.70406"},{"key":"2121_CR10","doi-asserted-by":"publisher","first-page":"1323315","DOI":"10.3389\/fendo.2023.1323315","volume":"14","author":"FWA Waibel","year":"2024","unstructured":"Waibel FWA, U\u00e7kay I, Soldevila-Boixader L, Sydler C, Gariani K. Current knowledge of morbidities and direct costs related to diabetic foot disorders: a literature review. Front Endocrinol (Lausanne). 2024;14:1323315. https:\/\/doi.org\/10.3389\/fendo.2023.1323315.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2121_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1053\/j.semvascsurg.2023.01.007","volume":"36","author":"KM McDermott","year":"2023","unstructured":"McDermott KM, Bose S, Keegan A, Hicks CW. Disparities in limb preservation and associated socioeconomic burden among patients with diabetes and\/or peripheral artery disease in the united States. Semin Vasc Surg. 2023;36(1):39\u201348. https:\/\/doi.org\/10.1053\/j.semvascsurg.2023.01.007.","journal-title":"Semin Vasc Surg"},{"issue":"1","key":"2121_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12933-024-02201-6","volume":"23","author":"X Sun","year":"2024","unstructured":"Sun X, Zhang C, Ma Y, et al. Association between diabetes mellitus and primary restenosis following endovascular treatment: a comprehensive meta-analysis of randomized controlled trials. Cardiovasc Diabetol. 2024;23(1):132. https:\/\/doi.org\/10.1186\/s12933-024-02201-6.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2121_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ccd.28176","volume":"94","author":"M Anantha-Narayanan","year":"2019","unstructured":"Anantha-Narayanan M, Shah SM, Jelani, Q-U-A, et al. Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease: an updated meta-analysis of randomized controlled trials. Catheter Cardiovasc Interv. 2019;94(1):139\u201348. https:\/\/doi.org\/10.1002\/ccd.28176.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"2121_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1583\/13-4420R.1","volume":"21","author":"F Liistro","year":"2014","unstructured":"Liistro F, Angioli P, Porto I, et al. Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study. J Endovasc Ther. 2014;21(1):1\u20138. https:\/\/doi.org\/10.1583\/13-4420R.1.","journal-title":"J Endovasc Ther"},{"key":"2121_CR15","doi-asserted-by":"publisher","first-page":"1511268","DOI":"10.3389\/fcvm.2024.1511268","volume":"11","author":"J Li","year":"2024","unstructured":"Li J, Lu W, Lin L, et al. Comparison of clinical outcomes of drug-coated balloons angioplasty vs. plain old balloons angioplasty for peripheral arterial disease: an umbrella meta-analysis. Front Cardiovasc Med. 2024;11:1511268. https:\/\/doi.org\/10.3389\/fcvm.2024.1511268.","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"2121_CR16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/15385744211022598","volume":"55","author":"JM John","year":"2021","unstructured":"John JM, Samuel V, Selvaraj D, Premkumar P, Kota AA, Stephen E, Mani T. Comparison of clinical outcomes with drug coated balloons versus plain balloon angioplasty in chronic Limb-Threatening ischemia. Vasc Endovascular Surg. 2021;55(8):817\u201322. https:\/\/doi.org\/10.1177\/15385744211022598.","journal-title":"Vasc Endovascular Surg"},{"key":"2121_CR17","doi-asserted-by":"publisher","unstructured":"LI M. Guidelines and standards for comprehensive clinical diagnosis and interventional treatment for diabetic foot in China (Issue 7.0). J Interventional Med. 2021;4(3):117\u201329. https:\/\/doi.org\/10.1016\/j.jimed.2021.07.003","DOI":"10.1016\/j.jimed.2021.07.003"},{"issue":"5","key":"2121_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","volume":"131","author":"G Tepe","year":"2015","unstructured":"Tepe G, Laird J, Schneider P, et al. Drug-Coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-Month results from the IN.PACT SFA randomized trial. Circulation. 2015;131(5):495\u2013502.","journal-title":"Circulation"},{"issue":"1","key":"2121_CR19","first-page":"1","volume":"38","author":"AK Gabr","year":"2019","unstructured":"Gabr AK, Allam AK. A prospective, randomized study of drug-coated balloon versus plain old balloon angioplasty in management of femoropopliteal artery disease in diabetic patients: 12-month results. Egypt J Surg. 2019;38(1):1\u201311.","journal-title":"Egypt J Surg"},{"issue":"5","key":"2121_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","volume":"131","author":"G Tepe","year":"2015","unstructured":"Tepe G, Laird J, Schneider P, et al. Drug-Coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-Month results from the IN.PACT SFA randomized trial. Circulation. 2015;131(5):495\u2013502. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.011004.","journal-title":"Circulation"},{"issue":"6","key":"2121_CR21","doi-asserted-by":"publisher","first-page":"e007702","DOI":"10.1161\/CIRCINTERVENTIONS.118.007702","volume":"12","author":"JA Laird","year":"2019","unstructured":"Laird JA, Schneider PA, Jaff MR, et al. Long-Term clinical effectiveness of a Drug-Coated balloon for the treatment of femoropopliteal lesions: Five-Year outcomes from the IN.PACT SFA randomized trial. Circ Cardiovasc Interv. 2019;12(6):e007702. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.118.007702.","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"2121_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","volume":"7","author":"D Scheinert","year":"2014","unstructured":"Scheinert D, Duda S, Zeller T, et al. The LEVANT I (Lutonix Paclitaxel-Coated balloon for the prevention of femoropopliteal Restenosis) trial for femoropopliteal revascularization: First-in-Human randomized trial of Low-Dose Drug-Coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv. 2014;7(1):10\u20139. https:\/\/doi.org\/10.1016\/j.jcin.2013.05.022.","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"2121_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12933-025-02922-2","volume":"24","author":"M Frazzetto","year":"2025","unstructured":"Frazzetto M, Malakouti S, Khialani B, et al. Drug-coated balloons and diabetes: a review. Cardiovasc Diabetol. 2025;24(1):408. https:\/\/doi.org\/10.1186\/s12933-025-02922-2.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"2121_CR24","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.bbrc.2004.07.039","volume":"321","author":"BM Choi","year":"2004","unstructured":"Choi BM, Kim YM, Jeong YR, et al. Induction of Heme oxygenase-1 is involved in anti-proliferative effects of Paclitaxel on rat vascular smooth muscle cells. Biochem Biophys Res Commun. 2004;321(4):868\u201374. https:\/\/doi.org\/10.1016\/j.bbrc.2004.07.039.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2121_CR25","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.3390\/ijms26052196","volume":"26","author":"P Karakasis","year":"2025","unstructured":"Karakasis P, Theofilis P, Patoulias D, et al. Diabetes-driven atherosclerosis: updated mechanistic insights and novel therapeutic strategies. Int J Mol Sci. 2025;26(5):2196. https:\/\/doi.org\/10.3390\/ijms26052196.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2121_CR26","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1002\/ccd.70028","volume":"106","author":"C Wang","year":"2025","unstructured":"Wang C, Chen L, Xu X. The predictive value of quantitative flow ratio and its derived angiographic microvascular resistance for restenosis following drug-coated balloon angioplasty. Catheter Cardiovasc Interv. 2025;106(3):1951\u20137. https:\/\/doi.org\/10.1002\/ccd.70028.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"07","key":"2121_CR27","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1055\/a-2499-9856","volume":"85","author":"S Reuter","year":"2025","unstructured":"Reuter S, Bajorat R, M\u00fcller-Graf F, et al. The role of microcirculatory dysfunction during Paclitaxel treatment as a critical co-factor for the development of chemotherapy-induced peripheral neuropathy. Geburtshilfe Und Perinatologie. 2025;85(07):710\u201323. https:\/\/doi.org\/10.1055\/a-2499-9856.","journal-title":"Geburtshilfe Und Perinatologie"},{"issue":"4","key":"2121_CR28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1177\/1358863X241231942","volume":"29","author":"M Zhang","year":"2024","unstructured":"Zhang M, Lotfollahzadeh S, Elzinad N, et al. Alleviating iatrogenic effects of Paclitaxel via antiinflammatory treatment. Vasc Med. 2024;29(4):369\u201380. https:\/\/doi.org\/10.1177\/1358863X241231942.","journal-title":"Vasc Med"},{"issue":"36","key":"2121_CR29","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","volume":"45","author":"L Mazzolai","year":"2024","unstructured":"Mazzolai L, Teixido-Tura G, Lanzi S, et al. 2024 ESC guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. 2024;45(36):3538\u2013700. https:\/\/doi.org\/10.1093\/eurheartj\/ehae179.","journal-title":"Eur Heart J"},{"issue":"1","key":"2121_CR30","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","volume":"58","author":"GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS)","year":"2019","unstructured":"GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS). European society for vascular surgery (ESVS), and world federation of vascular societies (WFVS). Global vascular guidelines on the management of chronic Limb-Threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58(1):S1\u2013Se10933. https:\/\/doi.org\/10.1016\/j.ejvs.2019.05.006.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2121_CR31","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 13. Older adults: Standards of Care in Diabetes\u20142024. Diabetes Care. 2024;47(Suppl. 1):S244-S257. https:\/\/doi.org\/10.2337\/dc24-S013","DOI":"10.2337\/dc24-S013"},{"issue":"2","key":"2121_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/15266028231179589","volume":"32","author":"T B\u00f6hme","year":"2025","unstructured":"B\u00f6hme T, Zeller T, Shishehbor MH, et al. Chocolate touch versus Lutonix Drug-Coated balloon for femoropopliteal lesions in diabetes: the chocolate touch study. J Endovasc Ther. 2025;32(2):414\u201322. https:\/\/doi.org\/10.1177\/15266028231179589.","journal-title":"J Endovasc Ther"},{"issue":"33","key":"2121_CR33","doi-asserted-by":"publisher","first-page":"e39331","DOI":"10.1097\/MD.0000000000039331","volume":"103","author":"F Zhang","year":"2024","unstructured":"Zhang F, Song HX, Zheng LH, An YB, Liu P. Long-term clinical efficacy of drug-coated balloon angioplasty for TASCII C\/D femoropopliteal lesions in older patients with chronic limb-threatening ischemia: A retrospective study. Med (Baltim). 2024;103(33):e39331. https:\/\/doi.org\/10.1097\/MD.0000000000039331.","journal-title":"Med (Baltim)"},{"issue":"8S","key":"2121_CR34","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.carrev.2017.04.015","volume":"18","author":"LM Palena","year":"2017","unstructured":"Palena LM, Diaz-Sandoval LJ, Manzi M. Drug-coated balloon angioplasty for the management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia. Cardiovasc Revasc Med. 2017;18(8S):S10\u20135. https:\/\/doi.org\/10.1016\/j.carrev.2017.04.015.","journal-title":"Cardiovasc Revasc Med"},{"key":"2121_CR35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s12928-024-00999-2","volume":"39","author":"Y Shima","year":"2024","unstructured":"Shima Y, Taninobu N, Ikuta A, et al. Two-year outcomes of endovascular therapy for femoropopliteal arterial lesions for patients with high bleeding risk. Cardiovasc Interv Ther. 2024;39:284\u201392. https:\/\/doi.org\/10.1007\/s12928-024-00999-2.","journal-title":"Cardiovasc Interv Ther"},{"issue":"1","key":"2121_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/life13010047","volume":"13","author":"A Vison\u00e0","year":"2023","unstructured":"Vison\u00e0 A, Prandoni P, Cusumano C, et al. Bleeding risk in patients with peripheral arterial disease. Life (Basel). 2023;13(1):47. https:\/\/doi.org\/10.3390\/life13010047. Published 2022 Dec 23.","journal-title":"Life (Basel)"},{"key":"2121_CR37","doi-asserted-by":"publisher","first-page":"1511268","DOI":"10.3390\/fcvm.2024.1511268","volume":"11","author":"CI Cheng","year":"2024","unstructured":"Cheng CI, Wu YW, Chen YH, et al. Real-world data on endovascular treatment with a drug-coated balloon in patients with peripheral arterial disease at high risk for bleeding. Front Cardiovasc Med. 2024;11:1511268. https:\/\/doi.org\/10.3390\/fcvm.2024.1511268. Published 2024 May 30.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"2121_CR38","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ccd.31257","volume":"104","author":"M Verdoia","year":"2024","unstructured":"Verdoia M, Nardin M, Saglietto A, et al. Drug-coated balloons in high-risk patients and diabetes mellitus: A meta-analysis of 10 studies. Catheter Cardiovasc Interv. 2024;104(2):331\u20139. https:\/\/doi.org\/10.1002\/ccd.31257.","journal-title":"Catheter Cardiovasc Interv"},{"key":"2121_CR39","doi-asserted-by":"publisher","first-page":"993290","DOI":"10.3389\/fcvm.2022.993290","volume":"9","author":"J Guo","year":"2022","unstructured":"Guo J, Ning Y, Wang H, et al. The efficacy and safety of different endovascular modalities for infrapopliteal arteries lesions: A network meta-analysis of randomized controlled trials. Front Cardiovasc Med. 2022;9:993290. https:\/\/doi.org\/10.3389\/fcvm.2022.993290. Published 2022 Nov 9.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2121_CR40","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/ccd.31581","volume":"106","author":"Y Gou\u00ebffic","year":"2025","unstructured":"Gou\u00ebffic Y, Dubosq-Lebaz M, Heautot JF, Tricotel A, Sauguet A. Paclitaxel-Coated balloons for femoropopliteal artery disease treatment in French patients: A longitudinal observational study. Catheter Cardiovasc Interv. 2025;106(1):680\u201390. https:\/\/doi.org\/10.1002\/ccd.31581.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"2121_CR41","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/jcm13051508","volume":"13","author":"M Piechocki","year":"2024","unstructured":"Piechocki M, Przew\u0142ocki T, Pieni\u0105\u017cek P, Trystu\u0142a M, Podolec J, Kab\u0142ak-Ziembicka A. A, Non-Coronary, peripheral arterial atherosclerotic disease (Carotid, Renal, lower Limb) in elderly patients\u2014A review PART II\u2014Pharmacological approach for management of elderly patients with peripheral atherosclerotic lesions outside coronary territory. J Clin Med. 2024;13(5):1508. https:\/\/doi.org\/10.3390\/jcm13051508. Published 2024 Mar 5.","journal-title":"J Clin Med"},{"issue":"6","key":"2121_CR42","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/j.jvs.2025.07.048","volume":"82","author":"H Chamseddine","year":"2025","unstructured":"Chamseddine H, Halabi M, Shepard A, et al. Popliteal-distal bypass versus infra-popliteal endovascular therapy for infra-popliteal occlusive disease. J Vasc Surg. 2025;82(6):2123\u2013e21323. https:\/\/doi.org\/10.1016\/j.jvs.2025.07.048.","journal-title":"J Vasc Surg"},{"key":"2121_CR43","doi-asserted-by":"publisher","unstructured":"N\u00fa\u00f1ez-Castellanos CA, Esquinca-Morales MF, Beristain-Bola\u00f1os MC, et al. Comparison of safety and efficacy of femoropopliteal arterial disease using different dose drug-coated balloons: systematic review and meta-analysis. Vascular Published Online Dec. 2024;14. https:\/\/doi.org\/10.1177\/17085381241307765.","DOI":"10.1177\/17085381241307765"},{"issue":"6","key":"2121_CR44","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1177\/15266028241241967","volume":"32","author":"T Fransson","year":"2025","unstructured":"Fransson T, Sturedahl AD, Resch T, Bj\u00f6rn E, Gotts\u00e4ter A. Nationwide study of the outcome of treatment of lower extremity atherosclerotic lesions with endovascular surgery with or without drug eluting methods in patients with diabetes. J Endovasc Ther. 2025;32(6):2196\u2013207. https:\/\/doi.org\/10.1177\/15266028241241967.","journal-title":"J Endovasc Ther"},{"key":"2121_CR45","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.avsg.2022.07.007","volume":"87","author":"TI Kim","year":"2022","unstructured":"Kim TI, Loh S, DeWan A, et al. Major adverse limb events among patients with premature peripheral artery disease compared with those at the common age undergoing revascularization in the vascular quality initiative. Ann Vasc Surg. 2022;87:188\u201397. https:\/\/doi.org\/10.1016\/j.avsg.2022.07.007.","journal-title":"Ann Vasc Surg"},{"issue":"1 Pt B","key":"2121_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.carrev.2017.06.006","volume":"19","author":"LM Palena","year":"2018","unstructured":"Palena LM, Diaz-Sandoval LJ, Gomez-Jaballera E, et al. Drug-coated balloon angioplasty for the management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia. Cardiovasc Revasc Med. 2018;19(1 Pt B):83\u20137. https:\/\/doi.org\/10.1016\/j.carrev.2017.06.006.","journal-title":"Cardiovasc Revasc Med"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02121-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02121-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02121-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:56:06Z","timestamp":1775116566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02121-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2121"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02121-3","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Tianjin People\u2019s Hospital (Approval No. B74 of 2025). Informed consent was obtained from all the participants. All methods were carried out in accordance with Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"92"}}